The HPV vaccine prevents cancer in men, too. Why don’t more people get it?

Ahead of the American Society of Clinical Oncology meeting, new data show just how much the vaccine reduces the risk of HPV-related cancers.

May 24, 2024 Check out STAT+

Sponsored By

Wellcome New data show the HPV vaccine prevents cancer in men, too. Why don't more people get it? New data show the vaccine reduced the risk of HPV-related cancers by 56% in men and 36% in women — numbers that actually probably understate its efficacy. By Matthew Herper STAT+ | FDA advisers endorse Guardant Health's colon cancer screening test Guardant Health's blood-based colon cancer detection test was endorsed for FDA approval by an independent panel of advisers. By Angus Chen and Jonathan Wosen STAT+ | Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical The drug, JNJ-6420, is designed to treat metastatic castration-resistant prostate cancer by delivering radioactive isotopes directly to cancer cells. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser